{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:13:38Z","timestamp":1791922418424,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070272"],"award-info":[{"award-number":["82070272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Beijing Research Ward Excellence Clinical Study Program","award":["BRWEP2024W014090201"],"award-info":[{"award-number":["BRWEP2024W014090201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-04902-z","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:45:02Z","timestamp":1768527902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FHOD3 deficiency disrupts sarcomere organization and activates caMKII signaling in human stem cell-derived cardiomyocytes"],"prefix":"10.1186","volume":"17","author":[{"given":"Mingyu","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"2","key":"4902_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1515\/medgen-2025-2007","volume":"37","author":"G Yigit","year":"2025","unstructured":"Yigit G, Kaulfu\u00df S, Wollnik B. Understanding inherited cardiomyopathies: clinical aspects and genetic determinants. Medizinische Genetik: Mitteilungsblatt Des Berufsverbandes Medizinische Genetik eV. 2025;37(2):103\u201311.","journal-title":"Medizinische Genetik: Mitteilungsblatt Des Berufsverbandes Medizinische Genetik eV"},{"key":"4902_CR2","doi-asserted-by":"crossref","unstructured":"Voinescu OR, Ionac A, Sosdean R, Ionac I, Ana LS, Kundnani NR et al. Genotype-Phenotype insights of inherited Cardiomyopathies-A review. Med (Kaunas Lithuania). 2024;60(4).","DOI":"10.3390\/medicina60040543"},{"issue":"8","key":"4902_CR3","doi-asserted-by":"publisher","first-page":"e010687","DOI":"10.1161\/CIRCHEARTFAILURE.123.010687","volume":"16","author":"E Monda","year":"2023","unstructured":"Monda E, Bakalakos A, Rubino M, Verrillo F, Diana G, De Michele G, et al. Targeted therapies in pediatric and adult patients with hypertrophic heart disease: from molecular pathophysiology to personalized medicine. Circulation Heart Fail. 2023;16(8):e010687.","journal-title":"Circulation Heart Fail"},{"issue":"4","key":"4902_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.cell.2025.01.011","volume":"188","author":"VN Parikh","year":"2025","unstructured":"Parikh VN, Day SM, Lakdawala NK, Adler ED, Olivotto I, Seidman CE, et al. Advances in the study and treatment of genetic cardiomyopathies. Cell. 2025;188(4):901\u201318.","journal-title":"Cell"},{"issue":"43","key":"4902_CR5","doi-asserted-by":"publisher","first-page":"29873","DOI":"10.1074\/jbc.M109.059303","volume":"284","author":"K Taniguchi","year":"2009","unstructured":"Taniguchi K, Takeya R, Suetsugu S, Kan OM, Narusawa M, Shiose A, et al. Mammalian Formin fhod3 regulates actin assembly and sarcomere organization in striated muscles. J Biol Chem. 2009;284(43):29873\u201381.","journal-title":"J Biol Chem"},{"issue":"6","key":"4902_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1083\/jcb.201005060","volume":"191","author":"T Iskratsch","year":"2010","unstructured":"Iskratsch T, Lange S, Dwyer J, Kho AL, dos Remedios C, Ehler E. Formin follows function: a muscle-specific isoform of FHOD3 is regulated by CK2 phosphorylation and promotes myofibril maintenance. J Cell Biol. 2010;191(6):1159\u201372.","journal-title":"J Cell Biol"},{"issue":"5","key":"4902_CR7","doi-asserted-by":"publisher","first-page":"e018236","DOI":"10.1161\/JAHA.120.018236","volume":"10","author":"G Wu","year":"2021","unstructured":"Wu G, Ruan J, Liu J, Zhang C, Kang L, Wang J, et al. Variant spectrum of Formin homology 2 Domain-Containing 3 gene in Chinese patients with hypertrophic cardiomyopathy. J Am Heart Association. 2021;10(5):e018236.","journal-title":"J Am Heart Association"},{"issue":"12","key":"4902_CR8","doi-asserted-by":"publisher","first-page":"e0294969","DOI":"10.1371\/journal.pone.0294969","volume":"18","author":"N Vodnjov","year":"2023","unstructured":"Vodnjov N, Topli\u0161ek J, Maver A, \u010cuturilo G, Jakli\u010d H, Teran N, et al. A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans-A cohort study. PLoS ONE. 2023;18(12):e0294969.","journal-title":"PLoS ONE"},{"key":"4902_CR9","doi-asserted-by":"crossref","unstructured":"Myasnikov R, Bukaeva A, Kulikova O, Meshkov A, Kiseleva A, Ershova A et al. A case of severe Left-Ventricular noncompaction associated with splicing altering variant in the FHOD3 gene. Genes. 2022;13(2).","DOI":"10.3390\/genes13020309"},{"issue":"3","key":"4902_CR10","doi-asserted-by":"publisher","first-page":"e0172995","DOI":"10.1371\/journal.pone.0172995","volume":"12","author":"U Esslinger","year":"2017","unstructured":"Esslinger U, Garnier S, Korniat A, Proust C, Kararigas G, M\u00fcller-Nurasyid M, et al. Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy. PLoS ONE. 2017;12(3):e0172995.","journal-title":"PLoS ONE"},{"issue":"20","key":"4902_CR11","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.jacc.2018.10.001","volume":"72","author":"JP Ochoa","year":"2018","unstructured":"Ochoa JP, Sabater-Molina M, Garc\u00eda-Pinilla JM, Mogensen J, Restrepo-C\u00f3rdoba A, Palomino-Doza J, et al. Formin homology 2 domain containing 3 (FHOD3) is a genetic basis for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2018;72(20):2457\u201367.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"4902_CR12","doi-asserted-by":"publisher","first-page":"e3146","DOI":"10.1002\/jgm.3146","volume":"22","author":"S Huang","year":"2020","unstructured":"Huang S, Pu T, Wei W, Xu R, Wu Y. Exome sequencing identifies a FHOD3 p.S527del mutation in a Chinese family with hypertrophic cardiomyopathy. J Gene Med. 2020;22(3):e3146.","journal-title":"J Gene Med"},{"issue":"5","key":"4902_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/jmg-2023-109413","volume":"61","author":"J Piqueras-Flores","year":"2024","unstructured":"Piqueras-Flores J, Villacorta-Arg\u00fcelles E, Galvin J, Climent-Pay\u00e1 V, Escobar-L\u00f3pez LE, Amor-Salamanca A, et al. Intermediate-effect size p.Arg637Gln in FHOD3 increases risk of HCM and is associated with an aggressive phenotype in homozygous carriers. J Med Genet. 2024;61(5):423\u20137.","journal-title":"J Med Genet"},{"issue":"12","key":"4902_CR14","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1253\/circj.CJ-13-0255","volume":"77","author":"T Arimura","year":"2013","unstructured":"Arimura T, Takeya R, Ishikawa T, Yamano T, Matsuo A, Tatsumi T, et al. Dilated cardiomyopathy-associated FHOD3 variant impairs the ability to induce activation of transcription factor serum response factor. Circulation Journal: Official J Japanese Circulation Soc. 2013;77(12):2990\u20136.","journal-title":"Circulation Journal: Official J Japanese Circulation Soc"},{"issue":"9","key":"4902_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1242\/bio.20121370","volume":"1","author":"OM Kan","year":"2012","unstructured":"Kan OM, Takeya R, Abe T, Kitajima N, Nishida M, Tominaga R, et al. Mammalian Formin Fhod3 plays an essential role in cardiogenesis by organizing myofibrillogenesis. Biology Open. 2012;1(9):889\u201396.","journal-title":"Biology Open"},{"issue":"1","key":"4902_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1074\/jbc.M117.813931","volume":"293","author":"T Ushijima","year":"2018","unstructured":"Ushijima T, Fujimoto N, Matsuyama S, Kan OM, Kiyonari H, Shioi G, et al. The actin-organizing Formin protein Fhod3 is required for postnatal development and functional maintenance of the adult heart in mice. J Biol Chem. 2018;293(1):148\u201362.","journal-title":"J Biol Chem"},{"key":"4902_CR17","doi-asserted-by":"crossref","unstructured":"Liu C, Shao NY. The differences in the developmental stages of the cardiomyocytes and endothelial cells in human and mouse embryos at the Single-Cell level. Int J Mol Sci. 2024;25(6).","DOI":"10.3390\/ijms25063240"},{"issue":"8","key":"4902_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41419-019-1826-4","volume":"10","author":"X Li","year":"2019","unstructured":"Li X, Lu WJ, Li Y, Wu F, Bai R, Ma S, et al. MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling. Cell Death Dis. 2019;10(8):610.","journal-title":"Cell Death Dis"},{"issue":"8","key":"4902_CR19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"PW Burridge","year":"2014","unstructured":"Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, et al. Chemically defined generation of human cardiomyocytes. Nat Methods. 2014;11(8):855\u201360.","journal-title":"Nat Methods"},{"issue":"3","key":"4902_CR20","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1161\/CIRCRESAHA.117.312067","volume":"122","author":"L Sala","year":"2018","unstructured":"Sala L, van Meer BJ, Tertoolen LGJ, Bakkers J, Bellin M, Davis RP, et al. MUSCLEMOTION: A versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo. Circul Res. 2018;122(3):e5\u201316.","journal-title":"Circul Res"},{"issue":"3","key":"4902_CR21","doi-asserted-by":"publisher","first-page":"H373","DOI":"10.1152\/ajpheart.00534.2021","volume":"322","author":"A Rhoden","year":"2022","unstructured":"Rhoden A, Schulze T, Pietsch N, Christ T, Hansen A, Eschenhagen T. Comprehensive analyses of the inotropic compound Omecamtiv mecarbil in rat and human cardiac preparations. Am J Physiol Heart Circ Physiol. 2022;322(3):H373\u201385.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"4902_CR22","doi-asserted-by":"publisher","first-page":"e020860","DOI":"10.1161\/JAHA.121.020860","volume":"10","author":"S Shen","year":"2021","unstructured":"Shen S, Sewanan LR, Jacoby DL, Campbell SG. Danicamtiv enhances systolic function and Frank-Starling behavior at minimal diastolic cost in engineered human myocardium. J Am Heart Association. 2021;10(12):e020860.","journal-title":"J Am Heart Association"},{"key":"4902_CR23","doi-asserted-by":"crossref","unstructured":"Zaffran S, Kraoua L, Jaouadi H. Calcium handling in inherited cardiac diseases: A focus on catecholaminergic polymorphic ventricular tachycardia and hypertrophic cardiomyopathy. Int J Mol Sci. 2023;24(4).","DOI":"10.3390\/ijms24043365"},{"issue":"2","key":"4902_CR24","doi-asserted-by":"publisher","first-page":"113507","DOI":"10.1016\/j.yexcr.2023.113507","volume":"424","author":"M Gartz","year":"2023","unstructured":"Gartz M, Haberman M, Sutton J, Slick RA, Luttrell SM, Mack DL, et al. ACTA1 H40Y mutant iPSC-derived skeletal myocytes display mitochondrial defects in an in vitro model of nemaline myopathy. Exp Cell Res. 2023;424(2):113507.","journal-title":"Exp Cell Res"},{"key":"4902_CR25","doi-asserted-by":"crossref","unstructured":"Pi\u00f1ero-P\u00e9rez R, L\u00f3pez-Cabrera A, \u00c1lvarez-C\u00f3rdoba M, Cilleros-Holgado P, Talaver\u00f3n-Rey M, Su\u00e1rez-Carrillo A et al. Actin polymerization defects induce mitochondrial dysfunction in cellular models of nemaline myopathies. Antioxid (Basel Switzerland). 2023;12(12).","DOI":"10.3390\/antiox12122023"},{"key":"4902_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/5584_2017_106","volume":"1067","author":"J Gambardella","year":"2018","unstructured":"Gambardella J, Trimarco B, Iaccarino G, Santulli G. New insights in cardiac calcium handling and Excitation-Contraction coupling. Adv Exp Med Biol. 2018;1067:373\u201385.","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"4902_CR27","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/CIRCRESAHA.117.310355","volume":"121","author":"M Dewenter","year":"2017","unstructured":"Dewenter M, von der Lieth A, Katus HA, Backs J. Calcium signaling and transcriptional regulation in cardiomyocytes. Circul Res. 2017;121(8):1000\u201320.","journal-title":"Circul Res"},{"issue":"11","key":"4902_CR28","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1002\/mco2.772","volume":"5","author":"S Huang","year":"2024","unstructured":"Huang S, Li J, Li Q, Wang Q, Zhou X, Chen J, et al. Cardiomyopathy: pathogenesis and therapeutic interventions. MedComm. 2024;5(11):e772.","journal-title":"MedComm"},{"key":"4902_CR29","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.5114\/amsad\/205547","volume":"10","author":"M Kallash","year":"2025","unstructured":"Kallash M, Frishman WH, Aronow WS. Omecamtiv mecarbil, a cardiac myosin activator with potential efficacy in heart failure. Archives Med Sci Atherosclerotic Dis. 2025;10:e43\u20137.","journal-title":"Archives Med Sci Atherosclerotic Dis"},{"issue":"10","key":"4902_CR30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4070\/kcj.2021.0154","volume":"51","author":"KH Kim","year":"2021","unstructured":"Kim KH, Pereira NL. Genetics of cardiomyopathy: clinical and mechanistic implications for heart failure. Korean Circulation J. 2021;51(10):797\u2013836.","journal-title":"Korean Circulation J"},{"key":"4902_CR31","doi-asserted-by":"publisher","first-page":"855763","DOI":"10.3389\/fcell.2022.855763","volume":"10","author":"H Tani","year":"2022","unstructured":"Tani H, Tohyama S. Human engineered heart tissue models for disease modeling and drug discovery. Front Cell Dev Biology. 2022;10:855763.","journal-title":"Front Cell Dev Biology"},{"issue":"1","key":"4902_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s13287-025-04484-2","volume":"16","author":"M Jiang","year":"2025","unstructured":"Jiang M, Chen X, Song Y, Wei M, Cao J, Lu W, et al. NEXN deficiency leads to dilated cardiomyopathy in human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther. 2025;16(1):402.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"4902_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","volume":"53","author":"AR Harper","year":"2021","unstructured":"Harper AR, Goel A, Grace C, Thomson KL, Petersen SE, Xu X, et al. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity. Nat Genet. 2021;53(2):135\u201342.","journal-title":"Nat Genet"},{"issue":"4","key":"4902_CR34","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1253\/circj.CJ-14-0182","volume":"78","author":"K Sallam","year":"2014","unstructured":"Sallam K, Kodo K, Wu JC. Modeling inherited cardiac disorders. Circulation Journal: Official J Japanese Circulation Soc. 2014;78(4):784\u201394.","journal-title":"Circulation Journal: Official J Japanese Circulation Soc"},{"issue":"4","key":"4902_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/cvr\/cvv024","volume":"105","author":"I Olivotto","year":"2015","unstructured":"Olivotto I, d\u2019Amati G, Basso C, Van Rossum A, Patten M, Emdin M, et al. Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations. Cardiovascular Res. 2015;105(4):409\u201323.","journal-title":"Cardiovascular Res"},{"key":"4902_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.yjmcc.2020.08.018","volume":"148","author":"TG Martin","year":"2020","unstructured":"Martin TG, Kirk JA. Under construction: the dynamic assembly, maintenance, and degradation of the cardiac sarcomere. J Mol Cell Cardiol. 2020;148:89\u2013102.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"4902_CR37","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.stemcr.2022.02.016","volume":"17","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Li X, Guo T, Lu WJ, Ma S, Chang Y, et al. Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes. Stem Cell Rep. 2022;17(4):804\u201319.","journal-title":"Stem Cell Rep"},{"issue":"6","key":"4902_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.125.071523","volume":"152","author":"L Ye","year":"2025","unstructured":"Ye L, Liu J, Lei W, Ni B, Han X, Zhang Y, et al. Disruption of cTnT-Mediated Sarcomere-Mitochondrial communication results in dilated cardiomyopathy. Circulation. 2025;152(6):397\u2013415.","journal-title":"Circulation"},{"issue":"21","key":"4902_CR39","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","volume":"144","author":"S Ranjbarvaziri","year":"2021","unstructured":"Ranjbarvaziri S, Kooiker KB, Ellenberger M, Fajardo G, Zhao M, Vander Roest AS, et al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation. 2021;144(21):1714\u201331.","journal-title":"Circulation"},{"issue":"13","key":"4902_CR40","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/eurheartj\/ehad028","volume":"44","author":"EE Nollet","year":"2023","unstructured":"Nollet EE, Duursma I, Rozenbaum A, Eggelbusch M, W\u00fcst RCI, Schoonvelde SAC, et al. Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration. Eur Heart J. 2023;44(13):1170\u201385.","journal-title":"Eur Heart J"},{"issue":"1","key":"4902_CR41","doi-asserted-by":"publisher","first-page":"15422","DOI":"10.1038\/s41598-024-62530-0","volume":"14","author":"H Mori","year":"2024","unstructured":"Mori H, Xu D, Shimoda Y, Yuan Z, Murakata Y, Xi B, et al. Metabolic remodeling and calcium handling abnormality in induced pluripotent stem cell-derived cardiomyocytes in dilated phase of hypertrophic cardiomyopathy with MYBPC3 frameshift mutation. Sci Rep. 2024;14(1):15422.","journal-title":"Sci Rep"},{"issue":"4","key":"4902_CR42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10741-009-9146-x","volume":"14","author":"SE Lehnart","year":"2009","unstructured":"Lehnart SE, Maier LS, Hasenfuss G. Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart. Heart Fail Rev. 2009;14(4):213\u201324.","journal-title":"Heart Fail Rev"},{"issue":"2","key":"4902_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1161\/CIRCRESAHA.123.322504","volume":"133","author":"M Ni","year":"2023","unstructured":"Ni M, Li Y, Wei J, Song Z, Wang H, Yao J, et al. Increased Ca(2+) transient underlies RyR2-Related left ventricular noncompaction. Circul Res. 2023;133(2):177\u201392.","journal-title":"Circul Res"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-04902-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04902-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04902-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:05:16Z","timestamp":1770771916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-04902-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4902"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-04902-z","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human embryonic stem cell line WAe009-A used in this study was obtained from WiCell Research Institute, Inc., and is registered with the Human Stem Cell Registry (hPSCreg), confirming ethical sourcing and use of human cells. Ethical approval and donor informed consent were obtained, which are available at\n                      \n                      . Our research adheres to all ethical guidelines and legal regulations, ensuring the use of the WAe009-A cell line meets the highest ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}